Neuromyelitis Optica Spectrum Disorders

DBCOND0067761Eye DiseaseGeneral system disorders NEC

Neuromyelitis Optica Spectrum Disorders is the indication for 4 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Neuromyelitis Optica Spectrum Disorder · NMO Spectrum Disorder (NMOSD) · NMO Spectrum Disorder · NMOSD
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT000880549ICD-10G36.0SNOMED CT25044007MedDRA10012574UMLSC0027873

What you can answer from here — as of October 24, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
83Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Neuromyelitis Optica Spectrum Disorders share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In